Correction: Zhang et al. Admission Serum Iron as an Independent Risk Factor for Postoperative Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: A Propensity-Matched Analysis. Brain Sci. 2022, 12, 1183
,
,
,
,
,
,
,
,
…
1
Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China
2
Department of Neurosurgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China
3
Department of Neurosurgery, The Second Affiliated Hospital, Fujian Medical University, Quanzhou 362000, China
4
2nd Department of Neurosurgery, “Attikon” University Hospital, Athens Medical School, National and Kapodistrian University, 999028 Athens, Greece
We would like to submit the following corrections to our recently published paper [1].
Error in the Text
The sentence correction on Page 8 needs correction:
In the original sentence, it was:
The matched DCI group had a significantly lower SI level than the matched non–DCI group (10.91 ± 6.86 vs. 20.34 ± 8.01 μmol/L, p < 0.001) (Table 1 and Figure 2D).
The correct sentence should be:
The matched DCI group had a significantly lower SI level than the matched non–DCI group (9.00 ± 6.29 vs. 20.13 ± 8.45 μmol/L, p < 0.001) (Table 1 and Figure 2D).
Errors in Tables
In the original publication, there was one mistake in Table 1 and two mistakes in Table 3. In Table 1, the number of patients from admission to surgical treatment (≤72 h) in the Non-DCI group was 77 after PSM. In Table 3, the number of patients with WFNS grade (IV–V) was 68 in the poor outcome before PSM, and the number of patients from admission to surgical treatment (≤72 h) in the good outcome group was 66 after PSM. The corrected Table 1 and Table 3 appear below.
Table 1.
Univariate analysis of association with DCI before and after propensity-score matching.
Table 1.
Univariate analysis of association with DCI before and after propensity-score matching.
Before Propensity-Score Matching
After Propensity-Score Matching
Characteristics
Non-DCI
DCI
p Value
Non-DCI
DCI
p Value
(n = 625)
(n = 105)
(n = 104)
(n = 104)
Age, yrs, mean ± SD
54.72 ± 11.47
55.65 ± 11.42
0.440
55.34 ± 11.22
55.76 ± 11.42
0.788
Gender (n, %)
0.513
1.00
Male
235 (37.6)
43 (41.0)
43 (41.3)
43 (41.3)
Female
390 (62.4)
62 (59.0)
61 (58.7)
61 (58.7)
Smoking (n, %)
112 (17.9)
16 (15.2)
0.504
23 (22.1)
16 (15.4)
0.214
Alcohol (n, %)
62 (9.9)
8 (7.6)
0.459
9 (8.7)
8 (7.7)
0.800
Medical history
Hypertension (n, %)
307 (49.1)
75 (71.4)
<0.001
81 (77.9)
74 (71.2)
0.218
Diabetes (n, %)
68 (10.9)
13 (12.4)
0.650
15 (14.4)
13 (12.4)
0.685
Coronary heart disease (n, %)
19 (3.0)
2 (1.9)
0.520
6 (5.8)
2 (1.9)
0.149
Hyperlipidemia (n, %)
119 (19.0)
15 (14.3)
0.244
25 (24.0)
15 (14.4)
0.079
WFNS grade
<0.001
0.114
I–III
535 (85.6)
73 (69.5)
82 (78.8)
72 (69.2)
IV–V
90 (14.4)
32 (30.5)
22 (21.2)
32 (30.8)
Modified Fisher grade
<0.001
0.078
1–2
482 (77.1)
64 (61.0)
75 (72.1)
63 (60.6)
3–4
143 (22.9)
41 (39.0)
29 (27.9)
41 (39.4)
Aneurysm characteristics (n, %)
Multiple aneurysms
115 (18.4)
23 (21.9)
0.396
17 (16.3)
23 (22.1)
0.291
Single aneurysm location
0.206
0.146
Anterior cerebral artery
33 (6.5)
2 (2.4)
7 (18.0)
2 (2.5)
Anterior communicating ar tery
164 (32.2)
30 (36.6)
32 (36.8)
29 (35.8)
Internal carotid artery
76 (14.9)
8 (9.8)
15 (17.2)
8 (9.9)
Middle cerebral artery
104 (20.4)
24 (29.3)
14 (16.1)
24 (29.6)
Posterior communicating artery
109 (21.4)
16 (19.5)
15 (17.2)
16 (19.8)
Others
24 (4.7)
2 (2.4)
4 (4.6)
2 (2.5)
Aneurysm size (n, %)
0.405
0.487
<5 mm
265 (42.4)
41 (39.0)
47 (45.2)
41 (39.4)
5–15 mm
299 (47.8)
53 (50.5)
48 (46.2)
52 (50.0)
15–25 mm
51 (8.2)
7 (6.7)
8 (7.7)
7 (6.7)
>25 mm
10 (1.6)
4 (3.8)
1 (1.0)
4 (3.8)
Surgical methods (n, %)
0.132
0.059
Clipping
399 (63.8)
75 (71.4)
61 (58.7)
74 (71.2)
Coiling
226 (36.2)
30 (28.6)
43 (41.3)
30 (28.8)
Time from admission to surgical treatment (n, %)
0.018
0.874
≤72 h
396 (63.4)
79 (75.2)
77 (74.0)
78 (75.0)
>72 h
229 (36.6)
26 (24.8)
27 (26.0)
26 (25.0)
Intracranial infection (n, %)
45 (7.2)
15 (14.3)
0.014
18 (17.3)
14 (13.5)
0.442
Hemoglobin, g/L, mean ± SD
128.73 ± 17.97
130.13 ± 18.63
0.475
134.32 ± 17.14
129.88 ± 18.53
0.074
Hematocrit, %, mean ± SD
38.19 ± 4.86
38.56 ± 4.88
0.473
39.47 ± 4.74
38.49 ± 4.85
0.144
Serum iron, umol/L, mean ± SD
13.11 ± 6.52
8.99 ± 6.26
<0.001
20.13 ± 8.45
9.00 ± 6.29
<0.001
modified Rankin Scale (n, %)
<0.001
<0.001
0–2
539 (86.2)
58 (55.2)
94 (90.4)
57 (54.8)
3–6
86 (13.8)
47 (44.8)
10 (9.6)
47 (45.2)
aSAH: aneurysmal subarachnoid hemorrhage; DCI: delayed cerebral ischemia mFisher: modified Fisher; SD: standard deviation; WFNS: World Federation of Neurosurgical Societies.
Table 3.
Univariate analysis of association with outcome in aSAH before and after propensity-score matching.
Table 3.
Univariate analysis of association with outcome in aSAH before and after propensity-score matching.
Before Propensity-Score Matching
After Propensity-Score Matching
Characteristics
Good Outcome
Poor Outcome
p Value
Good Outcome
Poor Outcome
p Value
(n = 597)
(n = 133)
(n = 93)
(n = 93)
Age, yrs, mean ± SD
54.17 ± 11.30
57.89 ± 11.69
0.001
56.53 ± 11.54
56.75 ± 11.57
0.894
Gender (n, %)
0.898
1.00
Male
228 (38.2)
50 (37.6)
34 (36.6)
34 (36.6)
Female
369 (61.8)
83 (62.4)
59 (63.4)
59 (63.4)
Smoking (n, %)
110 (18.4)
18 (10.5)
0.180
20 (21.5)
13 (14.0)
0.179
Alcohol (n, %)
60 (10.1)
10 (7.5)
0.356
10 (10.8)
7 (7.5)
0.445
Medical history
Hypertension (n, %)
293 (49.1)
89 (66.9)
<0.001
66 (71.0)
61 (65.6)
0.431
Diabetes (n, %)
63 (10.6)
18 (13.5)
0.322
13 (14.0)
11 (11.8)
0.662
Coronary heart disease (n, %)
16 (2.7)
5 (3.8)
0.501
1 (1.1)
2 (2.2)
0.561
Hyperlipidemia (n, %)
105 (17.6)
29 (21.8)
0.256
20 (21.5)
23 (34.7)
0.602
WFNS grade
<0.001
1.00
I–III
543 (90.1)
65 (48.9)
60 (64.5)
60 (64.5)
IV–V
54 (9.1)
68 (51.1)
33 (35.5)
33 (35.5)
Modified Fisher grade
<0.001
0.305
1–2
487 (81.6)
59 (44.4)
44 (47.3)
51 (54.8)
3–4
110 (18.4)
74 (55.6)
49 (52.7)
42 (45.2)
Aneurysm characteristics (n, %)
Multiple aneurysms
108 (18.1)
30 (22.6)
0.234
16 (17.2)
22 (23.7)
0.275
Single aneurysm location
0.196
0.648
Anterior cerebral artery
28 (5.3)
7 (6.8)
5 (6.5)
4 (5.6)
Anterior communicating artery
158 (32.3)
36 (35.0)
27 (35.1)
25 (35.2)
Internal carotid artery
63 (12.9)
21 (20.4)
8 (10.4)
13 (18.3)
Middle cerebral artery
107 (21.9)
21 (20.4)
16 (20.8)
16 (22.5)
Posterior communicating artery
109 (22.3)
16 (15.5)
18 (23.4)
12 (16.9)
Others
24 (4.9)
2 (1.9)
3 (3.9)
1 (1.4)
Aneurysm size (n, %)
0.570
0.594
<5 mm
246 (41.2)
60 (45.1)
37 (39.8)
44 (47.3)
5–15 mm
292 (48.9)
60 (45.1)
50 (53.8)
41 (44.1)
15–25 mm
49 (8.2)
9 (6.8)
4 (4.3)
6 (6.5)
>25 mm
10 (1.7)
4 (3.0)
2 (2.2)
4 (2.2)
Surgical methods (n, %)
0.260
0.117
Clipping
396 (63.3)
78 (58.6)
68 (73.1)
58 (62.4)
Coiling
201 (33.7)
55 (41.4)
25 (26.9)
35 (37.6)
Time from admission to surgical treatment (n, %)
0.370
0.633
≤72 h
384 (64.3)
91 (68.4)
66 (71.0)
63 (67.7)
>72 h
213 (35.7)
42 (31.6)
27 (29.0)
30 (32.3)
Intracranial infection (n, %)
48 (8.0)
12 (9.0)
0.709
8 (8.6)
7 (7.5)
0.788
Hemoglobin, g/L, mean ± SD
128.47 ± 17.69
131.02 ± 19.57
0.168
130.63 ± 16.48
130.71 ± 19.83
0.978
Hematocrit, %, mean ± SD
38.12 ± 4.81
38.79 ± 5.05
0.165
38.44 ± 4.43
38.74 ± 5.00
0.664
Serum iron, umol/L, mean ± SD
13.40 ± 6.80
8.59 ± 3.96
<0.001
17.32 ± 9.90
9.38 ± 4.00
<0.001
DCI (n, %)
58 (9.7)
47 (35.3)
<0.001
23 (24.7)
22 (23.7)
0.864
aSAH: aneurysmal subarachnoid hemorrhage; DCI: delayed cerebral ischemia mFisher: modified Fisher; SD: standard deviation; WFNS: World Federation of Neurosurgical Societies.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
Zhang, Y.-B.; Zheng, F.; Stavrinou, L.; Wang, H.-J.; Fan, W.-J.; Yao, P.-S.; Lin, Y.-X.; Goldbrunner, R.; Zheng, S.-F.; Stavrinou, P.; et al. Admission Serum Iron as an Independent Risk Factor for Postoperative Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: A Propensity-Matched Analysis. Brain Sci.2022, 12, 1183. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.